MedPath

:NCPAP versus HHFNC in treatment of premature infants with respiratory distress

Phase 2
Conditions
respiratory distress syndrome in premature infants.
Respiratory distress syndrome of newborn
P22.0
Registration Number
IRCT20151122025184N2
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
54
Inclusion Criteria

premature infants with GA fewer than 37 weeks
premature infants with respiratory distress syndrome
premature infants with respiratory distress syndrome who can extubate after surfactant therapy

Exclusion Criteria

congenital heart diseases
asphyxia
septic shock
multiple anomaly

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The extubation failure rate in two groups of NCPAP and HHFNC within 7 days after the intervention. Timepoint: within 7 days after INSURE(intubation and surfactant injection and extubation). Method of measurement: EXAMINATION AND STUDY OF FILES.;The length of oxygen requirement after surfactant therapy. Timepoint: during after surfactant therapy. Method of measurement: EXAMINATION AND STUDY OF FILES.
Secondary Outcome Measures
NameTimeMethod
Pneumotorax and air leaks of the plural space due to the two type of noninvasive ventilation during the period of receiving respiratory support. Timepoint: During the period of receiving noninvasive respiratory support (intervention). Method of measurement: EXAMINATION AND CXR AND STUDY OF FILES.;Intraventricular brain hemorrhage during the period of receiving respiratory support. Timepoint: During the period of receiving noninvasive respiratory support (the intervention). Method of measurement: examination and brain sonography.;Hospital length of stay. Timepoint: The total length of hospitalization of the studied neonates. Method of measurement: study of files.;Nasal trauma includes ulceration and necrosis during the period of receiving respiratory support. Timepoint: During the period of receiving respiratory support(the intervention). Method of measurement: inspection.
© Copyright 2025. All Rights Reserved by MedPath